HCA Healthcare, Inc. HCA NYSE

HCA Healthcare, Inc. (HCA) generated $2.36B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $1.49B, free cash flow was $870M.

Free cash flow margin was 4.5% of revenue. Cash conversion ratio was 1.26x, indicating earnings are backed by cash.

The company returned $162M in dividends and $2.56B in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (25/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (72/100, Pass) — $870M (4.5% margin) supports a durable competitive advantage
• INCOME (45/100) — Cash conversion ratio was 1.26x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 61/100 with 5/7 criteria passed.